GlassScriptPhysician profile
Mimi W Zhang
NPI 1154768604
$7,080.13
in general payments reported to CMS, 2019-2025
52 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $525 · 2021: $1,555 · 2022: $2,384 · 2023: $1,895 · 2024: $315 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,296 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,296.41 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,151.06 | 2020-2024 | Erleada, Akeega, Abiraterone Acetate |
| Dendreon Pharmaceuticals LLC | $1,111.86 | 2019-2024 | Provenge |
| Sumitomo Pharma America, INC. | $428.83 | 2023 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $393.53 | 2019-2022 | |
| Myovant Sciences INC. | $388.84 | 2021-2022 | |
| Urovant Sciences INC | $296.34 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $267.56 | 2020-2023 | Xiaflex |
| Abbvie INC. | $247.88 | 2020-2023 | Botox, Lupron Depot |
| Bayer Healthcare Pharmaceuticals INC. | $239.44 | 2019-2023 | |
| Antares Pharma, INC. | $194.72 | 2020-2023 | Xyosted, Tlando, Nocdurna |
| Teleflex LLC | $185.25 | 2021-2024 | Urolift |
| Pfizer INC. | $171.60 | 2020-2023 | |
| Boston Scientific Corporation | $169.88 | 2019-2025 | Axonics |
| Urogen Pharma, INC. | $139.61 | 2021-2023 | Jelmyto |
| Merck Sharp & Dohme LLC | $135.40 | 2020-2023 | Welireg, Keytruda, Lynparza |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mimi Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.